Medicalook
Medicalook

Azopt

http://www.medicalook.com
Azopt

Azopt review





Azopt, defined as a carbonic anhydrase inhibitor, was developed by Alcon Laboratories and is commonly used to lower intraocular pressure (IOP) for patients suffering from ocular hypertension or open-angle glaucoma. Azopt is an ophthalmic solution commonly used to decrease the pressure in the patient's eye, IOP. IOP is associated with open-angle glaucoma and may cause vision loss or nerve damage if left untreated.

Carbonic anhydrase inhibitor or carbonic anhydrase II has the capability to decrease the aqueous humor secretion that results in the decrease of pressure in the anterior chamber of the eye.

The dose of Azopt differs based on the condition of the patient and prescription from their doctor. The recommended dose commonly found in the label of the medicament may differ according to the complexity of the IOP, as well as the diagnosis from your doctor regarding your condition.

Adults are recommended to use 1 drop on the afflicted eye 3 times a day. There should be at least 8 hours before the next treatment. Use of Azopt for children depends on the prescription and advice of your doctor.

Patients should exercise caution with the use of Azopt. In the case of a missed dose, don't double the treatment in a single setting. It is advisable to skip the missed dose and resume with the regular schedule.

Minor side effects caused by Azopt include vision problems (blurred vision), tearing, sour or bitter taste on your mouth, wamble and emesis, dizziness, and diarrhoea.

Adverse reactions to this medicament include stomach pains, rashes, bruising or bleeding, and acute pharyngitis. Patients might also suffer an allergic reaction to Azopt might experience the following symptoms:
• rashes
• skin edema
pruritus
• severe dizziness
• breathing problems

Talk with your doctor if these side effects persist during or after the treatment.

Patients are advised to consult with their doctor before using Azopt. The medicament might have adverse reactions with other medicaments that the patient is taking. Inform your doctor if you're using other ophthalmic solutions, other carbonic anhydrase inhibitors, salicylates with high doses, and painkillers.

It is also advisable to consult your doctor before using the medicament. Most doctors give their patients a full medical and physical examination to avoid complications and potential risks. It is also best to inform you doctor of previous conditions, as well as the medicaments you are currently using to give you an accurate prescription in regards to the use of the medicament. Individuals suffering from kidney or liver problems are advised to consult their doctor before undergoing treatment.

Azopt has the following structural formula:

Chemical structure of azopt


• Molecular formula of azopt is C12H21N3O5S3
• Chemical IUPAC Name is 2-ethylamino-4-(3-methoxypropyl)-5,5-dioxo-5$l^{6},7-dithia-4-azabicyclo[4.3.0]nona-8,10-diene-8-sulfonamide
• Molecular weight is 383.51 g/mol
Azopt available : ophthalmic suspension 1%

Generic name: Brinzolamide

  Your Azopt review